Chiron Real Estate Inc.
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
1D
-3.2%
1W
-9.7%
1M
-14.8%
6M
-16.4%
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~73% stronger price swings than usual
PRICE TARGET LOW
US$38.00
CONSENSUS
US$41.00
MEDIAN
US$41.50
PRICE TARGET HIGH
US$43.00
0
STRONG BUY
2
BUY
3
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Hold
As of: 13/07/2026
P/E
7.76
P/B
0.61
EV/EBITDA
6.49
RETURN ON EQUITY
10.1%
NET MARGIN
166.7%
DEBT/EQUITY
0.97
DIVIDEND YIELD
7.1%
AS OF
30/06/2026
FREE FLOAT
92.4%
FLOAT SHARES
12,233,079
AVG. DAILY VOLUME (30D)
120,350
Whitlock Matthew Fitzsimmons
Whitlock Matthew Fitzsimmons
Fitzgerald Charles
Decker Mark Okey Jr
Roseth Aaron Robert
Chiron Real Estate Inc. is a company in the Real Estate sector, REIT - Healthcare Facilities industry, headquartered in United States.
The CEO is Mark O. Decker Jr., the company employs around 30 people.
The IPO was on 29/06/2016; the stock trades on NYSE under the ticker XRN.
5 analysts rate the stock, the consensus is Hold (as of 13/07/2026).
The average price target is US$41.00, ranging from US$38.00 to US$43.00, with a median of US$41.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 73% stronger than usual.
Yes. The last dividend was US$0.16 per share, ex-date 20/11/2026, paid on 18/12/2026.
The dividend yield is 7.1% (as of 30/06/2026).
Comparable stocks include Welltower, Ventas, Healthpeak Properties, Healthcare Realty Trust, National Healthcare Properties, Prologis, Equinix and American Tower.
Clicking "Analyze stock" lets five strategies assess Chiron Real Estate against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.